Intimation under Regulation 30 of LODR.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals informed the exchange that its material subsidiary, Adita Bio Sys Private Limited, has received accreditation from the American Association for Laboratory Accreditation (A2LA). The accreditation covers testing of medical devices in the biological field under ISO/IEC 17025:2017 standards and A2LA R256 specific program requirements, aligned with US FDA Good Laboratory Practice (GLP) Regulations per 21 CFR Part 58. This allows the subsidiary to conduct internationally recognised, FDA-compliant testing of medical devices. The accreditation strengthens the subsidiary's capability to serve medical device clients needing regulatory-grade lab testing.
This is a positive capability milestone for the subsidiary, potentially opening doors to international medical device testing contracts, especially from US-bound clients. For shareholders, it enhances the credibility and revenue potential of the subsidiary, though no immediate financial numbers have been disclosed.